Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level.

Doi Y, Van Duin D.

Clin Infect Dis. 2019 Sep 12. pii: ciz627. doi: 10.1093/cid/ciz627. [Epub ahead of print] No abstract available.

PMID:
31513703
2.

Sex-Based Differences in Inpatient Burn Mortality.

Williams FN, Strassle PD, Knowlin L, Napravnik S, van Duin D, Charles A, Nizamani R, Jones SW, Cairns BA.

World J Surg. 2019 Sep 11. doi: 10.1007/s00268-019-05165-x. [Epub ahead of print]

PMID:
31511940
3.

The Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections.

Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, Harris A, Napravnik S, van Duin D.

Clin Infect Dis. 2019 Jun 19. pii: ciz528. doi: 10.1093/cid/ciz528. [Epub ahead of print]

PMID:
31219148
4.

Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.

Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00432-19. doi: 10.1128/AAC.00432-19. Print 2019 Aug.

PMID:
31182530
5.

Carbapenemase-producing organisms in solid organ transplantation.

Wong D, van Duin D.

Curr Opin Organ Transplant. 2019 Aug;24(4):490-496. doi: 10.1097/MOT.0000000000000664.

PMID:
31169529
6.

Predicting the preferred morphology of hexagonal boron nitride domain structure on nickel from ReaxFF-based molecular dynamics simulations.

Liu S, Comer J, van Duin ACT, van Duin DM, Liu B, Edgar JH.

Nanoscale. 2019 Mar 21;11(12):5607-5616. doi: 10.1039/c8nr10291k.

PMID:
30860524
7.

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria.

Watkins RR, Van Duin D.

Version 2. F1000Res. 2019 Jan 30 [revised 2019 Jan 1];8. pii: F1000 Faculty Rev-121. doi: 10.12688/f1000research.16517.2. eCollection 2019. Review.

8.

Researcher allegiance in research on psychosocial interventions: meta-research study protocol and pilot study.

Yoder WR, Karyotaki E, Cristea IA, van Duin D, Cuijpers P.

BMJ Open. 2019 Feb 19;9(2):e024622. doi: 10.1136/bmjopen-2018-024622.

9.

Development of the ReaxFF Methodology for Electrolyte-Water Systems.

Fedkin MV, Shin YK, Dasgupta N, Yeon J, Zhang W, van Duin D, van Duin ACT, Mori K, Fujiwara A, Machida M, Nakamura H, Okumura M.

J Phys Chem A. 2019 Mar 14;123(10):2125-2141. doi: 10.1021/acs.jpca.8b10453. Epub 2019 Mar 1.

PMID:
30775922
10.

The effect of rehabilitation combined with cognitive remediation on functioning in persons with severe mental illness: systematic review and meta-analysis.

van Duin D, de Winter L, Oud M, Kroon H, Veling W, van Weeghel J.

Psychol Med. 2019 Jul;49(9):1414-1425. doi: 10.1017/S003329171800418X. Epub 2019 Jan 30.

PMID:
30696500
11.

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D.

Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.

12.

China-United States Research Collaborations in Antimicrobial Resistance.

van Duin D, Gu P, Dong J, Pfaff M, Arias RM, Evans B, Yu Y, Li L, Zhang F, Liu Z, Cao B, Fowler VG Jr, Wang M.

Clin Infect Dis. 2018 Nov 13;67(suppl_2):S142-S145. doi: 10.1093/cid/ciy694. Erratum in: Clin Infect Dis. 2019 Mar 19;68(7):1254.

PMID:
30423056
13.

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).

Evans SR, Follmann D, Liu Y, Holland T, Doernberg SB, Rouphael N, Hamasaki T, Jiang Y, Lok JJ, Tran TTT, Harris AD, Fowler VG, Boucher H, Kreiswirth BN, Bonomo RA, Van Duin D, Paterson DL, Chambers H.

Clin Infect Dis. 2019 May 17;68(11):1961-1967. doi: 10.1093/cid/ciy912.

PMID:
30351426
14.

ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases.

Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Richter SS, van Duin D, Kreiswirth BN, Greco C, Fouts DE, Bonomo RA.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.

15.

Endemic Mycoses in Solid Organ Transplant Recipients.

Nel JS, Bartelt LA, van Duin D, Lachiewicz AM.

Infect Dis Clin North Am. 2018 Sep;32(3):667-685. doi: 10.1016/j.idc.2018.04.007. Review.

16.

Combined Medical and Surgical Management of Hepatic Mucormycosis in an Adult with Acute Myeloid Leukemia: Case Report and Review of the Literature.

Shah M, Nel J, Almansouri A, Van Duin D, Gerber DA.

Mycopathologia. 2019 Feb;184(1):155-158. doi: 10.1007/s11046-018-0289-y. Epub 2018 Jul 30. Review.

PMID:
30062389
17.

Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae.

Kanwar A, Marshall SH, Perez F, Tomas M, Jacobs MR, Hujer AM, Domitrovic TN, Rudin SD, Rojas LJ, Kreiswirth BN, Chen L, Quinones-Mateu M, van Duin D, Bonomo RA; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2018 Apr 23;5(4):ofy054. doi: 10.1093/ofid/ofy054. eCollection 2018 Apr.

18.

Reply to Elamin et al.

Lachiewicz AM, van Duin D.

Clin Infect Dis. 2018 Aug 31;67(6):982-983. doi: 10.1093/cid/ciy192. No abstract available.

19.

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.

Papp-Wallace KM, Barnes MD, Alsop J, Taracila MA, Bethel CR, Becka SA, van Duin D, Kreiswirth BN, Kaye KS, Bonomo RA.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00174-18. doi: 10.1128/AAC.00174-18. Print 2018 Jun.

20.

Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.

Richter SS, Karichu J, Otiso J, Van Heule H, Keller G, Cober E, Rojas LJ, Hujer AM, Hujer KM, Marshall S, Perez F, Rudin SD, Domitrovic TN, Kaye KS, Salata R, van Duin D, Bonomo RA.

Diagn Microbiol Infect Dis. 2018 May;91(1):89-92. doi: 10.1016/j.diagmicrobio.2018.01.005. Epub 2018 Jan 9.

21.

Successful Diagnosis of Intestinal Mycobacterium avium Complex Infection in a Kidney Transplant Recipient Using Nasogastric Aspirate Culture: A Case Report.

Parr JB, Lachiewicz AM, van Duin D, Chong PP.

Transplant Proc. 2017 Dec;49(10):2362-2364. doi: 10.1016/j.transproceed.2017.09.009.

22.

Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance.

Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D.

Clin Infect Dis. 2017 Nov 29;65(12):2130-2136. doi: 10.1093/cid/cix682. Review.

23.

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.

Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.

24.

Correction: Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.

Eitas TK, Stepp WH, Sjeklocha L, Long CV, Riley C, Callahan J, Sanchez Y, Gough P, Knowlin L, van Duin D, Ortiz-Pujols S, Jones SW, Maile R, Hong Z, Berger S, Cairns BA.

PLoS One. 2017 Nov 2;12(11):e0187785. doi: 10.1371/journal.pone.0187785. eCollection 2017.

25.

Risk Factors for Healthcare-Associated Infections in Adult Burn Patients.

Strassle PD, Williams FN, Weber DJ, Sickbert-Bennett EE, Lachiewicz AM, Napravnik S, Jones SW, Cairns BA, van Duin D.

Infect Control Hosp Epidemiol. 2017 Dec;38(12):1441-1448. doi: 10.1017/ice.2017.220. Epub 2017 Oct 30.

26.

Burn injury outcomes in patients with pre-existing diabetic mellitus: Risk of hospital-acquired infections and inpatient mortality.

Knowlin L, Strassle PD, Williams FN, Thompson R, Jones S, Weber DJ, van Duin D, Cairns BA, Charles A.

Burns. 2018 Mar;44(2):272-279. doi: 10.1016/j.burns.2017.09.022. Epub 2017 Oct 10.

27.

A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG Jr, Bonomo RA, van Duin D, Kaye KS; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Jul 27;4(3):ofx157. doi: 10.1093/ofid/ofx157. eCollection 2017 Summer.

28.

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Fowler VG Jr, Paterson DL, Bonomo RA, Evans S; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.

29.

Reply to Macesic et al.

van Duin D, Bonomo RA.

Clin Infect Dis. 2017 Aug 15;65(4):703-704. doi: 10.1093/cid/cix394. No abstract available.

30.

Systems-based Practice in Burn Care: Prevention, Management, and Economic Impact of Health Care-associated Infections.

Hultman CS, van Duin D, Sickbert-Bennett E, DiBiase LM, Jones SW, Cairns BA, Weber DJ.

Clin Plast Surg. 2017 Oct;44(4):935-942. doi: 10.1016/j.cps.2017.06.002. Epub 2017 Jul 29.

PMID:
28888319
31.

Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.

Eitas TK, Stepp WH, Sjeklocha L, Long CV, Riley C, Callahan J, Sanchez Y, Gough P, Knowlin L, van Duin D, Ortiz-Pujols S, Jones SW, Maile R, Hong Z, Berger S, Cairns BA.

PLoS One. 2017 Sep 8;12(9):e0184164. doi: 10.1371/journal.pone.0184164. eCollection 2017. Erratum in: PLoS One. 2017 Nov 2;12 (11):e0187785.

32.

Improving Research Enrollment of Severe Burn Patients.

Lachiewicz AM, Williams FN, Carson SS, Trexler JM, Nielsen CA, van Duin D, Weber DJ, Williams SD, Jones SW, Cairns BA.

J Burn Care Res. 2017 Sep/Oct;38(5):e807-e813. doi: 10.1097/BCR.0000000000000489.

33.

Even Better Than the Real Thing? Xenografting in Pediatric Patients with Scald Injury.

Diegidio P, Hermiz SJ, Ortiz-Pujols S, Jones SW, van Duin D, Weber DJ, Cairns BA, Hultman CS.

Clin Plast Surg. 2017 Jul;44(3):651-656. doi: 10.1016/j.cps.2017.02.001. Epub 2017 Apr 26. Review.

PMID:
28576254
34.

Life-threatening Skin Disorders Treated in the Burn Center: Impact of Health care-associated Infections on Length of Stay, Survival, and Hospital Charges.

Hermiz SJ, Diegidio P, Ortiz-Pujols S, Garimella R, Weber DJ, van Duin D, Hultman CS.

Clin Plast Surg. 2017 Jul;44(3):597-602. doi: 10.1016/j.cps.2017.02.006. Epub 2017 Apr 26.

PMID:
28576248
35.

NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.

Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RA.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00454-17. doi: 10.1128/AAC.00454-17. Print 2017 Jul.

36.

From VAP to VAE: Implications of the New CDC Definitions on a Burn Intensive Care Unit Population.

Lachiewicz AM, Weber DJ, van Duin D, Carson SS, DiBiase LM, Jones SW, Rutala WA, Cairns BA, Sickbert-Bennett EE.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):867-869. doi: 10.1017/ice.2017.63. Epub 2017 Apr 17.

37.

Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.

van Duin D.

Virulence. 2017 May 19;8(4):379-382. doi: 10.1080/21505594.2017.1306621. Epub 2017 Apr 12. No abstract available.

38.

Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.

Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG Jr, van Duin D.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02671-16. doi: 10.1128/AAC.02671-16. Print 2017 Jun.

39.

Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D; Gram-Negative Committee of the Antibacterial Resistance Leadership Group (ARLG)a.

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S30-S35. doi: 10.1093/cid/ciw829. Review.

40.

Atomistic Insights into Nucleation and Formation of Hexagonal Boron Nitride on Nickel from First-Principles-Based Reactive Molecular Dynamics Simulations.

Liu S, van Duin ACT, van Duin DM, Liu B, Edgar JH.

ACS Nano. 2017 Apr 25;11(4):3585-3596. doi: 10.1021/acsnano.6b06736. Epub 2017 Mar 24.

PMID:
28319661
41.

Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.

Wong D, van Duin D.

Drugs. 2017 Apr;77(6):615-628. doi: 10.1007/s40265-017-0725-1. Review.

42.

Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.

Florescu DF, Sonderup JL, Grant W, Chong PP, van Duin D, Kalil AC.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12692. Epub 2017 Apr 27.

PMID:
28273399
43.

Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG Jr, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RA.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02243-16. doi: 10.1128/AAC.02243-16. Print 2017 Apr.

44.

China's antibiotic resistance problems.

Paterson DL, van Duin D.

Lancet Infect Dis. 2017 Apr;17(4):351-352. doi: 10.1016/S1473-3099(17)30053-1. Epub 2017 Jan 28. No abstract available.

PMID:
28139428
45.

Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.

Hauck CG, Chong PP, Miller MB, Jamieson K, Fine JP, Foster MC, Shea TC, van Duin D.

Pathog Immun. 2016 Fall-Winter;1(2):234-242. doi: 10.20411/pai.v1i2.115.

46.

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.

Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.

47.

A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center.

Kanamori H, Parobek CM, Juliano JJ, van Duin D, Cairns BA, Weber DJ, Rutala WA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01516-16. doi: 10.1128/AAC.01516-16. Print 2017 Feb.

48.

Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation.

Chong PP, van Duin D, Sonderup JL, Grant WJ, Kalil AC, Florescu DF.

Clin Transplant. 2016 Nov;30(11):1488-1493. doi: 10.1111/ctr.12844. Epub 2016 Oct 6.

PMID:
27623481
49.

Improved Survival of Patients With Extensive Burns: Trends in Patient Characteristics and Mortality Among Burn Patients in a Tertiary Care Burn Facility, 2004-2013.

Strassle PD, Williams FN, Napravnik S, van Duin D, Weber DJ, Charles A, Cairns BA, Jones SW.

J Burn Care Res. 2017 May/Jun;38(3):187-193. doi: 10.1097/BCR.0000000000000456.

50.

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC.

Clin Ther. 2016 Nov;38(11):2468-2476. doi: 10.1016/j.clinthera.2016.09.011. Epub 2016 Oct 19.

PMID:
27771176

Supplemental Content

Loading ...
Support Center